Rituxirel 500 mg Injection
495,56$
113,33$
Rituxirel 500 mg Injection is a powerful monoclonal antibody designed to target and deplete specific immune cells, making it an essential option in the treatment of various immune-related conditions. This medication is primarily utilized for managing certain types of cancers, particularly non-Hodgkin's lymphoma and chronic lymphocytic leukemia, by disrupting the growth of malignant cells. By binding to the CD20 protein found on the surface of B cells, Rituxirel helps to inhibit the proliferation of these harmful cells, ultimately aiding in the restoration of a healthier immune response. Patients should be aware of potential side effects, including infusion reactions, increased risk of infections, and other serious conditions that may arise during treatment. Regular monitoring and communication with healthcare providers are crucial to ensure optimal outcomes. Rituxirel is administered via injection, allowing for direct delivery of the medication into the bloodstream, enhancing its effectiveness. As with any cancer treatment, it is vital to discuss individual health circumstances and treatment options with a qualified healthcare professional to ensure safety and efficacy. This innovative therapy represents a significant advancement in oncology, providing hope for many patients facing challenging diagnoses.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Rituxirel 500 mg injection is primarily used in the treatment of Non-Hodgkin lymphoma (NHL). This medication works by targeting specific cells in the immune system, helping to reduce the number of cancerous cells. By doing so, Rituxirel 500 mg injection can slow down disease progression and improve patient outcomes. It is often administered in conjunction with other therapies to enhance effectiveness.
• Another significant application of Rituxirel 500 mg injection is in managing rheumatoid arthritis. In patients with this autoimmune condition, the drug helps to decrease inflammation and pain by targeting B cells, which play a role in the disease. This can lead to improved joint function and a better quality of life. Rituxirel 500 mg injection is typically considered for patients who have not responded well to other treatments.
• Rituxirel 500 mg injection is also indicated for the treatment of chronic lymphocytic leukaemia (CLL). This blood cancer affects the bone marrow and blood, leading to an accumulation of abnormal lymphocytes. By using Rituxirel 500 mg injection, healthcare providers can effectively reduce the number of these cancerous cells, allowing for better management of the disease. It is often part of a comprehensive treatment regimen tailored to the patient’s needs.
• Additionally, Rituxirel 500 mg injection is utilized in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. These are rare autoimmune conditions that cause inflammation of blood vessels. Rituxirel 500 mg injection helps to control the immune response, reducing symptoms and preventing further organ damage. This targeted therapy can be crucial for patients experiencing severe manifestations of these diseases.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Rituxirel 500 mg Vial has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Rituximab Injection 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Rituxirel 500 mg is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Rituxirel Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Rituxirel 500 mg reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Rituxirel 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Rituxirel 500 mg Vial is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Rituximab Injection 500 mg. Please consult your doctor.
• Kidney: Rituxirel 500 mg is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Rituxirel 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Rituxirel 500 mg Vial is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Anti-cancer Drug Rituxirel may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Rituximab Injection 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.